Rethinking the discharge policy for Ebola convalescents in an accelerating epidemic

Am J Trop Med Hyg. 2015 Feb;92(2):238-239. doi: 10.4269/ajtmh.14-0719. Epub 2014 Dec 1.

Abstract

The outbreak of Ebola virus disease (EVD) in West Africa has outstripped available resources. Novel strategies are desperately needed to streamline operations. The present norm of requiring negative results on polymerase chain reaction for EVD convalescent patients to be discharged is not evidence-based and often results in asymptomatic patients competing for beds in dangerously crowded Ebola Treatment Units, posing risks to ward staff and patients and the community if infected persons are turned away. We summarize the relevant data and call for a change in discharge criteria for convalescent patients that can safely help reduce the strain on resources and direct energies where they are most needed. In the longer term, research is needed to assess the true infectivity of EVD convalescent patients to establish evidence-based criteria and guidelines for discharge.

MeSH terms

  • Africa, Western / epidemiology
  • Epidemics / prevention & control*
  • Hemorrhagic Fever, Ebola / diagnosis
  • Hemorrhagic Fever, Ebola / epidemiology
  • Hemorrhagic Fever, Ebola / prevention & control
  • Hemorrhagic Fever, Ebola / therapy*
  • Hemorrhagic Fever, Ebola / transmission
  • Humans
  • Patient Discharge*
  • Polymerase Chain Reaction